Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Completed

• Conditions: Parkinson's Disease; Dyskinesia

• Registration Number: NCT01429207
• Lead Sponsor: Great Lakes NeuroTechnologies Inc.

Brief Summary

The purpose of the study is to test whether body-worn wireless motion sensors can measure dyskinesias (involuntary movements caused by medications) in individuals with Parkinson disease (PD) independent of voluntary activity being performed and other PD motor symptoms (e.g. tremor).

Detailed Description

Not available

Study Timeline

• Study Start: 2011-08
• Study First Submitted: 2011-09-02
• Study First Submitted QC: 2011-09-06
• Study First Posted: 2011-09-07
• Status Verified: 2012-06
• Last Update Submitted: 2012-06-28
• Last Update Posted: 2012-06-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

• Clinical diagnosis of probable or definite idiopathic Parkinson Disease with motor fluctuations that include dyskinesias after taking their usual dose of levodopa/carbidopa

Exclusion Criteria

• Antipsychotic medications (including quetiapine and clozapine)
• Coexisting neurologic disease such as stroke or dementia
• Lacking capacity for informed consent
• Residing in a nursing home
• comorbid non-neurologic illnesses that impacts the ability to perform the study tasks
• Implantable defibrillators

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

University of Rochester Medical Center; 🇺🇸 Rochester, New York, United States